Takeda
1422 articles with Takeda
-
Takeda Pharmaceutical Co. Ltd. Completes Subsequent Offering Period for Shares of Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)
5/14/2008
-
Nektar Therapeutics's PEGylation Technology Enables Peptide Mimetic, Highlighted by Data Presented at 45th ERA-EDTA Congress
5/12/2008
-
Takeda Pharmaceutical Co. Ltd. Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) and Announces Subsequent Offering Period
5/9/2008
-
Abbott Laboratories, Takeda Pharmaceutical Co. Ltd. Conclude TAP Joint Venture
5/1/2008
-
FDA Approves AMITIZA(R) for the Treatment of Irritable Bowel Syndrome with Constipation in Adult Women; Medicine Marketed by Takeda Pharmaceutical Co. Ltd. and Its Developer, Sucampo Pharmaceuticals, Inc.
4/30/2008
-
Biotech Blossoms Anew
4/30/2008
-
Takeda Pharmaceutical Co. Ltd. and Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) Announce Early Termination of Hart-Scott-Rodino Waiting Period
4/29/2008
-
Takeda Pharmaceutical Co. Ltd. New Data Published in Circulation Showed an Increase in HDL Cholesterol Levels with ACTOS(R) (pioglitazone HCl)
4/16/2008
-
Chemizon Inc. Announces a Second Expansion of Collaboration with Takeda Pharmaceutical Co. Ltd.
4/16/2008
-
Takeda Pharmaceutical Co. Ltd. Commences Cash Tender Offer for all Outstanding Shares of Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts)
4/14/2008
-
Affymax, Inc. and Takeda Pharmaceutical Co. Ltd. Report Long-Term Safety and Effectiveness Data of Hematide in Chronic Renal Failure Patients With Anemia
4/4/2008
-
Cell Genesys, Inc. to Webcast Conference Call to Discuss Global Alliance Formed With Takeda Pharmaceutical Co. Ltd. for the Development and Commercialization of GVAX Immunotherapy for Prostate Cancer
4/1/2008
-
BG Medicine Joins the HRP Initiative to Discover Biomarkers of High-Risk Atherosclerotic Plaque
4/1/2008
-
Takeda Pharmaceutical Co. Ltd. Says to Drop Development of Cholesterol Drug
3/28/2008
-
Takeda Pharmaceutical Co. Ltd. to Pay Abbott Laboratories up to $1.5B in Venture Split
3/20/2008
-
Takeda Pharmaceutical Co. Ltd. Announces New U.S. Leadership
3/20/2008
-
Takeda Pharmaceutical Co. Ltd. to Buy Abbott Laboratories Stake in U.S. Venture
3/19/2008
-
PPD, Inc. Confirms Takeda Pharmaceutical Co. Ltd.'s NDA Filing of Alogliptin with FDA; Triggers $15M Milestone Payment
2/29/2008
-
Merck KGaA, Takeda Pharmaceutical Co. Ltd. Cancel Development of Cancer Drug
2/18/2008
-
Affymax, Inc. Affirms Progress with Takeda Pharmaceutical Co. Ltd. Collaboration
2/5/2008